MacroGenics
MGNX
#8652
Rank
A$0.33 B
Marketcap
A$5.28
Share price
-7.73%
Change (1 day)
107.87%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): A-$2.34

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$2.18. In 2025 the company made an earnings per share (EPS) of A-$1.68 a decrease over its 2024 EPS that were of A-$1.53.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.3438.78%
2025A-$1.6810.28%
2024A-$1.53613.33%
2023A-$0.21-92.31%
2022A-$2.78-42.14%
2021A-$4.8136.44%
2020A-$3.53-21.84%
2019A-$4.51-24.58%
2018A-$5.98675.93%
2017A-$0.77-68.05%
2016A-$2.41168.25%
2015A-$0.90-55%
2014A-$2.003400%
2013A-$0.05710-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.87-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.29-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.67-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$10.59-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.10-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.08-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$3.27 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA